These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8062539)

  • 1. Treatment of poorly controlled type 2 diabetes.
    Peters AL; Davidson MB
    Compr Ther; 1994; 20(6):321-5. PubMed ID: 8062539
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of diabetes mellitus in "secondary failure of sulfonylurea compounds"].
    Bachmann W
    Med Klin (Munich); 1987 Jun; 82(14):491-4. PubMed ID: 3302644
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
    Standl E; Schnell O
    Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term efficacy of steady-dose metformin in type 2 diabetes mellitus: a retrospective study.
    Drzewoski J; Czupryniak L
    Med Sci Monit; 2003 Jun; 9(6):CR240-3. PubMed ID: 12824953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
    Vannasaeng S; Ploybutr S; Nitiyanant W; Peerapatdit T; Vichayanrat A
    J Med Assoc Thai; 1995 Nov; 78(11):578-85. PubMed ID: 8576667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin initiation in Type 2 diabetes.
    Page S
    Diabet Med; 2005 Sep; 22 Suppl 4():2-5. PubMed ID: 16109011
    [No Abstract]   [Full Text] [Related]  

  • 7. Overview of current therapeutic options in type 2 diabetes. Rationale for combining oral agents with insulin therapy.
    Buse JB
    Diabetes Care; 1999 Apr; 22 Suppl 3():C65-70. PubMed ID: 10189565
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulin in the early management of diabetic complications.
    Miles JM
    J Assoc Physicians India; 2003 May; 51():501-5. PubMed ID: 12974435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.
    Kim HJ; Kang ES; Kim DJ; Kim SH; Ahn CW; Cha BS; Nam M; Chung CH; Lee KW; Nam CM; Lee HC
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):282-9. PubMed ID: 17224000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
    Goo AK; Carson DS; Bjelajac A
    J Fam Pract; 1996 Jun; 42(6):612-8. PubMed ID: 8656173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up of intensive glucose control in type 2 diabetes.
    Mühlhauser I
    N Engl J Med; 2009 Jan; 360(4):417; author reply 418. PubMed ID: 19172674
    [No Abstract]   [Full Text] [Related]  

  • 12. Incretin enhancers and the evolution of antihyperglycemic therapy in type 2 diabetes.
    Inzucchi SE
    Endocrinol Metab Clin North Am; 2007 Dec; 36 Suppl 2 Incretin():2-17. PubMed ID: 18405144
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological regulation of blood glucose levels in non-insulin-dependent diabetes mellitus.
    Bressler R; Johnson DG
    Arch Intern Med; 1997 Apr; 157(8):836-48. PubMed ID: 9129543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of glimepiride and metformin on free fatty acid in patients with Type 2 diabetes mellitus].
    Tang JZ; Mao JP; Yang ZF; Zhou ZG; Tang WL; Feng Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):631-4. PubMed ID: 16114544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycaemic control in type 2 diabetes.
    Campbell A
    Clin Evid; 2005 Dec; (14):474-90. PubMed ID: 16620416
    [No Abstract]   [Full Text] [Related]  

  • 16. Mathematical modeling shows exenatide improved beta-cell function in patients with type 2 diabetes treated with metformin or metformin and a sulfonylurea.
    Mari A; Nielsen LL; Nanayakkara N; DeFronzo RA; Ferrannini E; Halseth A
    Horm Metab Res; 2006 Dec; 38(12):838-44. PubMed ID: 17163361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glimepiride versus pioglitazone combination therapy in subjects with type 2 diabetes inadequately controlled on metformin monotherapy: results of a randomized clinical trial.
    Umpierrez G; Issa M; Vlajnic A
    Curr Med Res Opin; 2006 Apr; 22(4):751-9. PubMed ID: 16684436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of type 2 diabetes mellitus and the incretin system.
    Whitehill D
    S D Med; 2007 May; 60(5):197, 199. PubMed ID: 17694940
    [No Abstract]   [Full Text] [Related]  

  • 19. Diabetes 2000. Oral medications.
    Hoyson PM
    RN; 1995 May; 58(5):34-9; quiz 40. PubMed ID: 7747037
    [No Abstract]   [Full Text] [Related]  

  • 20. Follow-up of intensive glucose control in type 2 diabetes.
    Petrie JR
    N Engl J Med; 2009 Jan; 360(4):416-7; author reply 418. PubMed ID: 19172672
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.